PB1980: MULTIPLE MYELOMA: ADOPTING MRD BY NEXT GENERATION FLOW CYTOMETRY (NGF) AND FUNCTIONAL IMAGING GUIDED CONSOLIDATION INTO CLINICAL ROUTINE

por Boeckle, D., Tabares, P., Zhou, X., Schimanski, S., Steinhardt, M. J., Bittrich, M., Seebacher, E., Ulbrich, M., Wilnit, A., Metz, C., Heidemeier, A., Bley, T., Werner, R., Buck, A., Einsele, H., Kortüm, M., Beilhack, A., Rasche, L.
Publicado 2022

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma

por Solimando, A G, Brandl, A, Mattenheimer, K, Graf, C, Ritz, M, Ruckdeschel, A, Stühmer, T, Mokhtari, Z, Rudelius, M, Dotterweich, J, Bittrich, M, Desantis, V, Ebert, R, Trerotoli, P, Frassanito, M A, Rosenwald, A, Vacca, A, Einsele, H, Jakob, F, Beilhack, A
Publicado 2018